WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
1. (WO2006084410) NEW MACROLIDES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/084410    International Application No.:    PCT/CH2006/000083
Publication Date: 17.08.2006 International Filing Date: 08.02.2006
C07H 17/08 (2006.01), A61K 31/7048 (2006.01), A61P 31/04 (2006.01)
Applicants: BASILEA PHARMACEUTICA AG [CH/CH]; Grenzacherstrasse 487, CH-4005 Basel (CH) (For All Designated States Except US).
KELLENBERGER, Johannes, Laurenz [CH/CH]; (CH) (For US Only).
SHAPIRO, Stuart, Robert [CH/CH]; (CH) (For US Only).
MATHEWS, Salima [CH/CH]; (CH) (For US Only).
GUERRY, Philippe [CH/CH]; (CH) (For US Only).
BARBIER, Pierre, Jacques, Noël [FR/FR]; (FR) (For US Only)
Inventors: KELLENBERGER, Johannes, Laurenz; (CH).
SHAPIRO, Stuart, Robert; (CH).
MATHEWS, Salima; (CH).
GUERRY, Philippe; (CH).
BARBIER, Pierre, Jacques, Noël; (FR)
Agent: BOHEST INTELLECTUAL PROPERTY; A. Braun Braun Héritier Eschmann AG, Holbeinstrasse 36-38, CH-4051 Basel (CH)
Priority Data:
05002664.0 09.02.2005 EP
05011419.8 26.05.2005 EP
Abstract: front page image
(EN)The present invention relates to new antibiotic macrolide compounds of the general formula (I): with improved activity, to medicaments comprising such antibiotics, and to the use of such antibiotics for the treatment of infectious diseases, inflammatory diseases and human diseases or disorders which can be ameliorated by inhibition human phospdiesterases.
(FR)La présente invention se rapporte à de nouveaux composés macrolides antibiotiques de formule générale (I) : qui présentent une activité améliorée, à des médicaments comprenant ces antibiotiques et à l'utilisation de ces antibiotiques pour le traitement de maladies infectieuses, de maladies inflammatoires et de maladies humaines, ainsi que de troubles qui peuvent être améliorés par l'inhibition des phosphodiestérases humaines.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)